Learn More
Medchemexpress LLC MTX-531 | 2791417-66-6 | 99.9% | 453.94 | 50 MG

Supplier: Medchemexpress LLC HY16271350MG
MTX-531 is an oral drug that inhibits EGFR and PI3K, demonstrating anti-tumor effects. It also acts as a weak agonist of PPARγ, helping to alleviate hyperglycemia induced by PI3K inhibitors.
- Inhibits epidermal growth factor receptor.
- Inhibits phosphoinositide 3-kinase.
- Demonstrates anti-tumor effects.
- Acts as a weak agonist of peroxisome proliferator-activated receptors.
- Helps alleviate hyperglycemia.
- Suppresses tumor proliferation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.